Division of Rheumatology Archives
Aug. 25, 2022—An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.
Jun. 29, 2022— by Jill Clendening Patients whose race is recorded as Black in their electronic health record (EHR) are more likely to have azathioprine, an immunosuppressant medication, discontinued or its dose reduced because their laboratory results show a low white blood cell count. This lab finding was not a factor of race, but instead was linked...
Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
Sep. 16, 2021—Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
Apr. 20, 2021—Jason Springer, MD, MS, has joined Vanderbilt University Medical Center as associate professor of Medicine in the Division of Rheumatology and Immunology in the Department of Medicine. Springer is co-director of the Vanderbilt Vasculitis Center, where he will oversee vasculitis clinical trials.
Feb. 14, 2020—Vanderbilt University Medical Center will soon break ground on a new 31,000-square-foot facility that will offer adult outpatient specialty care, along with limited pediatric specialty care and imaging services to the citizens of Sumner and surrounding counties.
Oct. 30, 2019—Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.
Nov. 8, 2018—Vanderbilt University Medical Center recently debuted a new clinic dedicated to providing a multidisciplinary approach to caring for patients coping with the complex host of chronic disorders known as vasculitis.